rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2011-1-31
|
pubmed:databankReference |
|
pubmed:abstractText |
Xerostomia is the most common late side-effect of radiotherapy to the head and neck. Compared with conventional radiotherapy, intensity-modulated radiotherapy (IMRT) can reduce irradiation of the parotid glands. We assessed the hypothesis that parotid-sparing IMRT reduces the incidence of severe xerostomia.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-10635407,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-10655437,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-10725621,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-10814959,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-10884741,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-12203798,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-14967418,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-15010378,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-1591063,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-16199308,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-16475203,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-17145528,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-17154159,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-17289292,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-17551304,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-17706404,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-17971582,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-18355980,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-19111400,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-19332518,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-19446902,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-19596158,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-20409746,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-20554338,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-20817284,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-21277541,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-21451495,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-7713774,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-7713775,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-7713792,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-7818919,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-7880743,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-7917360,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-8433390,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-8892473,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-9109831,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-9440735,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-9635702,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21236730-9680919
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1474-5488
|
pubmed:author |
pubmed-author:A'HernRoger PRP,
pubmed-author:AdabFawziF,
pubmed-author:BhideShreerang ASA,
pubmed-author:ClarkCatharineC,
pubmed-author:EmsonMarieM,
pubmed-author:HallEmmaE,
pubmed-author:HarringtonKevin JKJ,
pubmed-author:JefferiesSarah JSJ,
pubmed-author:MiahAisha BAB,
pubmed-author:MilesElizabeth AEA,
pubmed-author:MordenJames PJP,
pubmed-author:NewboldKateK,
pubmed-author:NuttingChristopher MCM,
pubmed-author:PARSPORT trial management group,
pubmed-author:ScraseChristopherC,
pubmed-author:SydenhamMark AMA,
pubmed-author:TanayMaryAnneM,
pubmed-author:UrbanoTeresa GuerreroTG,
pubmed-author:YapBeng KBK
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
127-36
|
pubmed:dateRevised |
2011-7-26
|
pubmed:meshHeading |
pubmed-meshheading:21236730-Female,
pubmed-meshheading:21236730-Head and Neck Neoplasms,
pubmed-meshheading:21236730-Humans,
pubmed-meshheading:21236730-Longitudinal Studies,
pubmed-meshheading:21236730-Male,
pubmed-meshheading:21236730-Middle Aged,
pubmed-meshheading:21236730-Neoplasm Staging,
pubmed-meshheading:21236730-Parotid Gland,
pubmed-meshheading:21236730-Radiotherapy, Intensity-Modulated,
pubmed-meshheading:21236730-Xerostomia
|
pubmed:year |
2011
|
pubmed:articleTitle |
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
|
pubmed:affiliation |
Head and Neck Unit, Royal Marsden Hospitals NHS Foundation Trust, London, UK. chris.nutting@rmh.nhs.uk
|
pubmed:publicationType |
Journal Article,
Comparative Study
|